| Literature DB >> 31588877 |
Kristin Wiisanen Weitzel1, Benjamin Q Duong2, Meghan J Arwood1, Aniwaa Owusu-Obeng3, Noura S Abul-Husn3, Barbara A Bernhardt4, Brian Decker5, Joshua C Denny6, Eric Dietrich1, John Gums1, Ebony B Madden7, Toni I Pollin8, Rebekah Ryanne Wu9, Susanne B Haga9, Carol R Horowitz10.
Abstract
Pharmacogenetic testing can help identify primary care patients at increased risk for medication toxicity, poor response or treatment failure and inform drug therapy. While testing availability is increasing, providers are unprepared to routinely use pharmacogenetic testing for clinical decision-making. Practice-based resources are needed to overcome implementation barriers for pharmacogenetic testing in primary care.The NHGRI's IGNITE I Network (Implementing GeNomics In pracTicE; www.ignite-genomics.org) explored practice models, challenges and implementation barriers for clinical pharmacogenomics. Based on these experiences, we present a stepwise approach pharmacogenetic testing in primary care: patient identification; pharmacogenetic test ordering; interpretation and application of test results, and patient education. We present clinical factors to consider, test-ordering processes and resources, and provide guidance to apply test results and counsel patients. Practice-based resources such as this stepwise approach to clinical decision-making are important resources to equip primary care providers to use pharmacogenetic testing.Entities:
Keywords: clinic; implementation; pharmacogenetics; pharmacogenomics; precision medicine; primary care
Mesh:
Year: 2019 PMID: 31588877 PMCID: PMC6854439 DOI: 10.2217/pgs-2019-0053
Source DB: PubMed Journal: Pharmacogenomics ISSN: 1462-2416 Impact factor: 2.533